Cause of death during upper tract urothelial carcinoma survivorship: A contemporary, population-based analysis

被引:0
|
作者
Peng, Fu-Sheng [1 ]
Wu, Wan-Ting [2 ]
Zhang, Lu [2 ]
Shen, Jia-Hua [3 ]
Yu, Dong-Dong [1 ]
Mao, Li-Qi [4 ]
机构
[1] Huzhou Univ, Dept Urol, Affiliated Cent Hosp, Huzhou Cent Hosp, Huzhou, Peoples R China
[2] Huzhou Univ, Major Clin Med, Huzhou, Peoples R China
[3] Huzhou Wu Xing Dist Med Insurance Management Serv, Dept Med Insurance Fund Supervis Sect, Huzhou, Peoples R China
[4] Huzhou Univ, Affiliated Hosp 1, Peoples Hosp Huzhou 1, Dept Gastroenterol, Huzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
cause of death; upper urinary tract carcinoma; standardized mortality ratios (SMRs); excess absolute risks (EARs); surveillance epidemiology and end results (SEER); TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; SURVIVAL; URETER; PELVIS; RISK;
D O I
10.3389/fonc.2022.948289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundVery few studies have been published on the causes of death of upper tract urothelial carcinoma (UTUC). We sought to explore the mortality patterns of contemporary UTUC survivors. MethodsWe performed a retrospective cohort study involving patients with upper urinary tract carcinoma from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database (2000 and 2015). We used standardized mortality ratios (SMRs) to compare death rates among patients with UTUC in the general population and excess absolute risks (EARs) to quantify the disease-specific death burden. ResultsA total of 10,179 patients with UTUC, including 7,133 who died, were included in our study. In total, 302 (17.17%) patients with the localized disease died of UTUC; however, patients who died from other causes were 4.8 times more likely to die from UTUC (n = 1,457 [82.83%]). Cardiovascular disease was the most common non-cancer cause of death (n = 393 [22.34% of all deaths]); SMR, 1.22; 95% confidence intervals [CI], 1.1-1.35; EAR, 35.96). A total of 4,046 (69.99%) patients with regional stage died within their follow-up, 1,413 (34.92%) of whom died from UTUC and 1,082 (26.74%) of whom died from non-cancer causes. UTUC was the main cause of death (SMR, 242.48; 95% CI, 230-255.47; EAR, 542.47), followed by non-tumor causes (SMR, 1.18; 95% CI, 1.11-1.25; EAR, 63.74). Most patients (94.94%) with distant stage died within 3 years of initial diagnosis. Although UTUC was the leading cause of death (n = 721 [54.29%]), these patients also had a higher risk of death from non-cancer than the general population (SMR, 2.08; 95% CI, 1.67-2.56; EAR, 288.26). ConclusionsNon-UTUC deaths accounted for 82.48% of UTUC survivors among those with localized disease. Patients with regional/distant stages were most likely to die of UTUC; however, there is an increased risk of dying from non-cancer causes that cannot be ignored. These data provide the latest and most comprehensive assessment of the causes of death in patients with UTUC.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] COMPREHENSIVE ANALYSIS OF UPPER URINARY TRACT UROTHELIAL CARCINOMA
    Fujii, Yoichi
    Sato, Yusuke
    Suzuki, Hiromichi
    Yoshizato, Tetsuichi
    Shiozawa, Yusuke
    Yoshida, Kenichi
    Shiraishi, Yuichi
    Nakagawa, Tohru
    Nishimatsu, Hiroaki
    Sanada, Masashi
    Makishima, Hideki
    Miyano, Satoru
    Ogawa, Seishi
    Kume, Haruki
    JOURNAL OF UROLOGY, 2018, 199 (04): : E776 - E776
  • [42] Predictors of Upper Tract Urothelial Cell Carcinoma After Primary Bladder Cancer: A Population Based Analysis COMMENT
    Jones, J. Stephen
    JOURNAL OF UROLOGY, 2009, 181 (03): : 1039 - 1039
  • [43] PROGNOSTIC FACTORS IN A CONTEMPORARY COHORT OF PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (UTUC)
    Staehler, Michael
    Mayer, Vanessa
    Graser, Anabel
    Rodler, Severin
    Tamaluans, Alexander
    Stief, Christian
    Schlenker, Boris
    JOURNAL OF UROLOGY, 2020, 203 : E322 - E323
  • [44] Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma
    Ruvolo, Claudia Colla
    Nocera, Luigi
    Stolzenbach, L. Franziska
    Wenzel, Mike
    Cucchiara, Vito
    Tian, Zhe
    Shariat, Shahrokh F.
    Saad, Fred
    Longo, Nicola
    Montorsi, Francesco
    Briganti, Alberto
    Mirone, Vincenzo
    Karakiewicz, Pierre, I
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (05): : 792 - 801
  • [45] CONTEMPORARY CONCEPTS AND CONTROVERSIES IN THE DIAGNOSIS AND MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA (UTUC)
    Shariat, S. F.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 22 - 22
  • [46] Risk of acute myocardial infarction in upper tract urothelial carcinoma patients receiving radical nephroureterectomy: a population-based cohort study
    Lin, Shih-Yi
    Lin, Cheng-Li
    Chang, Chao-Hsiang
    Wu, His-Chin
    Wang, I-Kuan
    Chou, Che-Yi
    Liang, Ji-An
    ONCOTARGET, 2017, 8 (45) : 79498 - 79506
  • [47] Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study
    Hu, Jiasheng
    Gu, Haowen
    Zhang, Dongxu
    Wen, Min
    Yan, Zejun
    Song, Baiyang
    Xie, Chengxin
    BMC UROLOGY, 2024, 24 (01):
  • [48] A nomogram for overall survival of second primary cancers following upper-tract urothelial carcinoma: a SEER population-based study
    Zhang, Xi
    Chen, Weikang
    Li, Chunming
    Wan, Xiaojie
    Xu, Peifeng
    Zhang, Tao
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (08) : 4131 - 4145
  • [49] Nomograms to predict overall and cancer-specific survival in patients with upper tract urothelial carcinoma: a large population-based study
    Qi, Feng
    Wei, Xiyi
    Zheng, Yuxiao
    Sha, Yeqin
    Lu, Yousheng
    Li, Xiao
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 1177 - 1191
  • [50] CONTEMPORARY UTILIZATION TRENDS OF SYSTEMIC CHEMOTHERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA (UTUC)
    Haseebuddin, Mohammed
    Handorf, Elizabeth
    Jones, Joshua
    Kutikov, Alexander
    Waingankar, Nikhil
    Ristau, Benjamin
    Haifler, Michael
    Wong, Yu-Ning
    Viterbo, Rosalia
    Greenberg, Richard
    Uzzo, Robert
    Chen, David
    Smaldone, Marc
    JOURNAL OF UROLOGY, 2016, 195 (04): : E285 - E286